<! html public "-//W3C//DTD HTML 4.01 Transitional//EN">

<html>
<head>
<meta name="Sperowider-ArchiveRoot" content="../../../../../">
<meta name="Sperowider-DocRoot" content="../../../">
<meta name="Sperowider-OriginalURL" content="http://www.erowid.org/archive/rhodium/chemistry/doef.html">
<title>Synthesis of 2,5-Dimethoxy-4-Fluoroethyl-amphetamine (DOEF) - [www.rhodium.ws]</title>
<link href="../styles.css" rel="stylesheet" type="text/css">
</head>

<body>
<div style="border:black solid 1px;">
<div style="border:white solid 1px; padding:.25em; color: white; font: 700 9pt arial,sans-serif; background-color: darkblue;">
This file is a part of the Rhodium site archive. This Aug 2004 static snapshot is hosted by Erowid<br>
as of May 2005 and is not being updated. <a href="../index.html" style="color:white;">&gt; &gt; Back to Rhodium Archive Index &gt; &gt; </a>
</div>
</div>

<div class="top">
<a href="../rhodium.html">[www.rhodium.ws]</a> [] <a href="index.html">[Chemistry Archive]</a>
<br><form method="get" action="http://www.erowid.org/cgi-bin/search/htsearch.php?method=and&restrict=www.erowid.org%2Farchive%2Frhodium%2F&words=barron"><input type="hidden" name="config" value=""><input type="hidden" name="restrict" value=""><input type="hidden" name="exclude" value=""><input type="text" size="29" name="words" value="">&nbsp;<input type="submit" value="Search"></form>
<div class="spacer">&nbsp;</div>
</div>

<div class="header">
<h2>Synthesis of 2,5-Dimethoxy-4-Fluoroethylamphetamine (DOEF)</h2>
  <h4>By Alexander T. Shulgin, Tet. Lett. 29(50), 6537-6540 (1988)</h4>
<p>HTML by Rhodium</p>
</div>

<div class="stdtxt">

<div class="abstract">
<h3>Abstract</h3>
<p>Synthesis of the titled 2,5-dimethoxy-4-fluoroalkylamphetamine is reported. The highly functionalized aromatic nucleus of the key fluorination precursor was ultimately derived from a low temperature aromatic halogen-lithium exchange reaction followed by alkylation of the resultant anion with ethylene oxide.</p>
</div>

	<div class="pic right">
    <img src="pictures/doef0.gif" width="350" height="231" border="0"> 
	</div>

  <p>Molecules possessing the 2,5-dimethoxyphenyl-2- aminopropane (2,5-dimethoxyamphetamine) 
    structural unit, which are appended with various substituents at the 4-position 
    (para) of the aromatic nucleus are known to function as psychoactive agents 
    in humans<a href="doef.html#refs"><sup>1</sup></a>. Included in the group of the most 
    potent psychotomimetic amphetamines known are the para-substituted bromide 
    <strong>1a</strong> (DOB) and ethyl derivative <strong>1b</strong> (DOET). 
    The hypothesis that the mode-of-action of these and related <em>para</em>-substituted 
    2,5-dimethoxy- amphetamines involves the stimulation of the cerebral serotonin 
    receptor system has been tested by evaluating their in vitro binding affinities 
    toward the 5-HT<sub>2</sub> and other serotonin receptor sub-types<a href="doef.html#refs"><sup>2</sup></a>. 
    The potential in vivo assessment of serotonin receptor populations using the 
    emerging technique of positron emission tomography<a href="doef.html#refs"><sup>3</sup></a> 
    (PET) provides impetus to further evaluate the structure-activity relationships 
    of molecules related to DOET, in particular <em>para</em>-fluoroalkyl-2,5-dimethoxyamphetamines. 
    Fluoroalkylamphetamines which exhibit favorable in vitro binding properties 
    will permit evaluation of fluorine-18 (<sup>18</sup>F) radiolabeled ligands 
    as potential PET imaging agents of the serotonin system.</p>
	
  <p>The biological potency of DOET <strong>1b</strong> coupled with the notion 
    that fluorinated pharmaceuticals may elicit biological activities similar 
    to the parent agents<a href="doef.html#refs"><sup>4</sup></a> has prompted the synthesis 
    of racemic 1-[2,5-dimethoxy- 4-(&beta;-fluoroethyl)phenyl]-2-aminopropane 
    (DOEF) <strong>1c</strong>. In this communication we describe the synthesis 
    of 1e employing a method which takes into account the constraints associated 
    with the potential preparation of <sup>18</sup>F-radiolabeled<a href="doef.html#refs"><sup>5</sup></a> 
    DOEF (<sup>18</sup>F-<strong>1c</strong>). The short half-life of fluorine-18 
    (110 min) would require a late synthetic introduction of the radiofluorine 
    atom and also that subsequent chemical transformations be rapid, convenient 
    and efficient. Based on these criteria tosyloxytrifluoroacetamide <strong>2</strong> 
    was selected as the key intermediate for DOEF production. Initially, the preparation 
    of the highly functionalized aromatic nucleus of <strong>2</strong> was envisaged 
    to follow a synthetic route similar to the one used for the formation of DOET<a href="doef.html#refs"><sup>6</sup></a>, 
    as outlined in <em>Scheme I</em>.</p>
	
	<div class="pic">
<h3>Scheme I</h3>
    <img src="pictures/doef1.gif" width="700" height="294" border="0"> 
    <p><strong>a.</strong> <em>n</em>-BuLi; ethylene oxide, 63%. <strong>b.</strong> 
      NaH; CH<sub>3</sub>I, 88%. <strong>c.</strong> POCl<sub>3</sub>, HCON(CH<sub>3</sub>)C<sub>6</sub>H<sub>5</sub>, 
      24%. <strong>d.</strong> NH<sub>4</sub>OAc, CH<sub>3</sub>CH<sub>2</sub>NO<sub>2</sub>, 
      70%. <strong>e.</strong> AlH<sub>3</sub>, 93%. <strong>f.</strong> TMSCl, 
      TMSI, 57%.</p>
</div>
	
  <p>Treatment of 1,4-dimethoxybenzene with <em>n</em>-butyllithium<a href="doef.html#refs"><sup>7</sup></a> 
    (1.1 mol, THF, 0�C, then reflux 4.5 h) followed by ethylene oxide quench<a href="doef.html#refs"><sup>8</sup></a> 
    (1.1 mol, ether, 0�C; hexane, reflux 5 h, 63%) afforded the corresponding 
    phenylethanol which was subsequently allowed to react with sodium hydride 
    (1.0 mol, THF, reflux, 16 h) and then with iodomethane (1.1 mol, THF, 0�C,15 
    min; 20�C, 10 h, 88%) to provide methylether <strong>3</strong><a href="doef.html#refs"><sup>9,10</sup></a>. 
    Formylation of the <em>para</em>-position under Vilsmeier conditions<a href="doef.html#refs"><sup>6</sup></a> 
    (POCl<sub>3</sub>, HCON(CH<sub>3</sub>)C<sub>6</sub>H<sub>5</sub>, 10 min, 
    100�C, 24%) afforded <em>para</em>-benzaldehyde <strong>4</strong>. Sidechain 
    elaboration of <strong>4</strong> to nitropropene <strong>5</strong><a href="doef.html#refs"><sup>11</sup></a> 
    (nitroethane 5 mol excess, cat. NH<sub>4</sub>OAc, 100�C, 2 h, 70 %) was followed 
    by aluminum hydride reduction<a href="doef.html#refs"><sup>12</sup></a> (5 mol LiAlH<sub>4</sub>, 
    100% H<sub>2</sub>SO<sub>4</sub>, THF, 0 �C; 20�C, 1 h; reflux 30 min, 95 
    %) to yield the corresponding aminoether. Deprotection of the methylethyl 
    ether moiety by the method of Jung<a href="doef.html#refs"><sup>13</sup></a> (TMSCl 
    2 mol, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 20�C, 30 min; then TMSI 
    1.3 mol, CHCl<sub>3</sub>, 20�C, 2 h, 57%) afforded aminoalcohol <strong>6</strong>. 
    The difficulty associated with the Vilsmeier transformation<a href="doef.html#refs"><sup>14</sup></a> 
    (<strong>3</strong> to <strong>4</strong>) precluded a useful large-scale 
    production of <strong>6</strong>, thus, an alternate synthesis was devised 
    according to the route shown in <em>Scheme II</em>.</p>
	
<div class="pic">
<h3>Scheme II</h3>
    <img src="pictures/doef2.gif" width="700" height="351" border="0"> 
    <p><strong>a.</strong> [ClSi(CH<sub>3</sub>)<sub>2</sub>CH<sub>2</sub>]<sub>2</sub>, 
      85%. <strong>b.</strong> <em>tert</em>-BuLi; ethylene oxide; KOH, 75%. <strong>c.</strong> 
      (CF<sub>3</sub>CO)<sub>2</sub>O; NaHCO<sub>3</sub>, 89%. <strong>d.</strong> 
      TsCl, 96%. <strong>e.</strong> TBAF, 55%. <strong>f.</strong> KOH, 86%.</p>
</div>	
	
	
  <p>The facile synthesis of <strong>6</strong> was effected by employing the 
    readily available starting material DOB<a href="doef.html#refs"><sup>15</sup></a>, Protection 
    of <strong>1a</strong> using Magnus' reagent<a href="doef.html#refs"><sup>16</sup></a> 
    ([ClSi(CH<sub>3</sub>)<sub>2</sub>CH<sub>2</sub>]<sub>2</sub> 1 mol, Et<sub>3</sub>N, 
    CH<sub>2</sub>Cl<sub>2</sub>, 20�C, 2 h, 85%) yielded bromodisilazane <strong>7</strong>. 
    Low temperature treatment of <strong>7</strong> with <em>tert</em>-butyllithium<a href="doef.html#refs"><sup>7,17</sup></a> 
    (2.1 mol, ether, -78�C, 15 min) followed by addition of ethylene oxide (1.5 
    mol, Et<sub>2</sub>O, -78�C, 1 h; then hexane, reflux, 3 h) and finally liberation 
    of the amine functionality under basic conditions<a href="doef.html#refs"><sup>16</sup></a> 
    (10% KOH, MeOH, reflux, 4 h) provided aminoalcohol <strong>6</strong> (75% 
    based on <strong>7</strong>). Subsequent formation of hydroxyacetamide <strong>8</strong> 
    was carried out with a two step procedure<a href="doef.html#refs"><sup>18</sup></a> 
    ((CF<sub>3</sub>CO)<sub>2</sub>O 2.5 mol, Et<sub>3</sub>N, Et<sub>2</sub>O, 
    0�C; 35�C, 1 h; then NaHCO<sub>3</sub> 1 mol, MeOH, H<sub>2</sub>O, 20�C, 
    3.5 h, 89%). </p>

  <p>Subjection of <strong>8</strong> to standard tosylation conditions (p-TsCl, 
    py, 0�C, 12 h, 96%) provided the desired tosylate <strong>2</strong>. Of the 
    many sources of fluoride ion reported to displace sulfonate esters<a href="doef.html#refs"><sup>19</sup></a> 
    treatment of <strong>2</strong> with a solution of commercially available 
    tetrabutylammonium fluoride (TBAF)<a href="doef.html#refs"><sup>20</sup></a> (1.5 mol, 
    THF, reflux, 30 min) afforded after separation (HPLC) fluorinated amide <strong>9</strong> 
    (55%) and styrene <strong>10</strong><a href="doef.html#refs"><sup>21 </sup></a>(18%). 
    Subsequent hydrolysis of the trifluoroacetamide protecting group of <strong>9</strong> 
    (KOH 1 mol, H<sub>2</sub>O, <em>i</em>-PrOH, 45�C, 30 min, 86%) yielded fluoroamphetamine 
    <strong>1c</strong>.</p>

  <p>In summary, the synthesis of <strong>1e</strong> was achieved in 8 steps 
    starting from DOB in an overall yield of 26%. The critical transformation 
    for the synthesis of key intermediate <strong>2</strong> involved a low temperature 
    halogen-lithium exchange reaction of <strong>7</strong> followed by alkylation 
    of the resultant anion with ethylene oxide. The method undoubtedly will prove 
    valuable for the construction of other molecules containing the 1,4-dialkyl-2,5-dimethoxybenzene 
    nucleus. Furthermore, the expedient (<75 min) and facile (47%) two-step transformation of tosylate><strong>2</strong> to DOEF is noteworthy, well-suited for the 
    production of radiolabeled <sup>18</sup>F-<strong>1c</strong> and provides 
    a general route to other fluoroalkylaromatic pharmaceuticals. The results 
    of the in vitro receptor binding affinity of <strong>1c</strong> toward the 
    5-HT<sub>2</sub> serotonin receptor and also the radiosynthesis of <sup>18</sup>F-<strong>1c</strong> 
    will be reported elsewhere.</p>


<div class="spacer"><h3>&nbsp;</h3></div>

</div>

<div class="refs">
	<a name="refs"></a>
	<h2>References and Notes</h2>
	
  <ol>
    <li><span class="oli">Shulgin, A. T. in Handbook of Experimental Pharmacology, 
      Vol. 55, Part 11, Psychotropic Agents; Hoffmeister, F.; Stille, G, Eds.; 
      Springer-Verlag: New York, 1982, pp 3-29.</span></li>
    <li><span class="oli">&nbsp; 
      <ol>
        <li><span class="oli">Titeler, M.; Lyon, R. A.; Glennon, R. A. Psychopharmacol. 
          1988, 94, 213. </span></li>
        <li><span class="oli">Wang, S, S.-H.; Mathis, C. A.; Peroutka, S. J. Psychopharmacol. 
          1988, 94, 431.</span></li>
      </ol>
      </span></li>
    <li><span class="oli">Wagner, H. N.; Bums, H. D.; Dannals, R. F.; Wong, D. 
      F.; Langstrom, B.; Dueller, T.; Frost, J. J.; Raven, H. E.; Links, J. M.; 
      Rosenbloom, S. B.; Lukas, S. E.; Kramer, A. V.; Kuhar, H. J. Science, 1983, 
      221, 1264.</span></li>
    <li><span class="oli">Biomedical Aspects of Fluorine Chemistry; Filler, R,; 
      Kobayashi, Y. Eds.; Kodansha Ltd.: Tokyo, 1982. </span></li>
    <li><span class="oli">The use of no-carrier-added fluorine-18 anion is the 
      method of choice for the production of high specific activity radiofluorinated 
      pharmaceuticals.</span></li>
    <li><span class="oli">Shulgin, A. T.; Dyer, D. C. J. Med. Chem. 1975, 18, 
      1201.</span></li>
    <li><span class="oli">For a recent review of heteroatom-facilitated lithiation 
      reactions see, Gschwend, H. W.; Rodriguez, H. R. Org. React. 1979, 26, 1.</span></li>
    <li><span class="oli">Conditions for organometallic opening of ethylene oxide 
      followed from Gaylord, N. G.; Becker, E. T. Chem. Rev. 1951, 49, 413.</span></li>
    <li><span class="oli">Direct quenching of the alkoxide resultant from ethylene 
      oxide ring opening with iodomethane occurred in a lower yield of <strong>3</strong> 
      relative to the two step procedure reported here.</span></li>
    <li><span class="oli">The spectroscopic qualities (<sup>1</sup>H NMR, IR) 
      and elemental analyses of all new compounds are in agreement with the assigned 
      structures.</span></li>
    <li><span class="oli">Nichols, D. E.; Barfknecht, C. F.; Rusterholz, D. B. 
      J. Med. Chem. 1973, 16, 482.</span></li>
    <li><span class="oli">Hydride reduction of related nitropropenes have been 
      reported previously<a href="doef.html#refs"><sup>6</sup></a>; the aluminum hydride 
      was prepared in situ, Yoon, N. M.; Brown, H. C. J. Am. Chem. Soc. 1968, 
      90, 2927.</span></li>
    <li><span class="oli">Protection of the amine as the bis-silylamide was followed 
      by ether cleavage, Jung, M. E.; Lyster, M. A. J. Org. Chem. 1977, 42, 3761.</span></li>
    <li><span class="oli">The laborious purification and low yield of <strong>4</strong> 
      by the Vilsmeier procedure necessitated attempting other <em>para</em>-formylation 
      reactions (dichloromethyl methyl ether with tin(IV)chloride and <em>n</em>-BuLi 
      with DMF) which proved unsuccessful for the conversion of <strong>3</strong> 
      to <strong>4</strong>.</span></li>
    <li><span class="oli">&nbsp; 
      <ol>
        <li><span class="oli">Shulgin, A. T.; Sargent, T.; Naranjo, C. Pharmacol. 
          1971, 5, 1031 </span></li>
        <li><span class="oli">Barfknecht, C. F.; Nichols, D. E. J. Med. Chem. 
          1971, 14, 370.</span></li>
      </ol>
      </span></li>
    <li><span class="oli">Djuric, S.; Venit, J.; Magnus, P. Tetrahedron Lett. 
      1981, 22, 1787.</span></li>
    <li><span class="oli">Jackiela, D. J.; Helquist, P.; Jones, L. D. Org. Syn. 
      1984, 62, 74 and references therein. </span></li>
    <li><span class="oli">Quick, J.; Meltz, C. J. Org. Chem. 1979, 44, 573,</span></li>
    <li><span class="oli">&nbsp; 
      <ol>
        <li><span class="oli">Sharts, C. M.; Shepard, W. A. Org. React. 1974, 
          21, 125. </span></li>
        <li><span class="oli">Cox, D. P.; Terpinski, J.; Lawrynowicz, W. J. Org. 
          Chem. 1984, 49, 3216 and references therein.</span></li>
      </ol>
      </span></li>
    <li><span class="oli">TBAF 1.0 M THF solution(< 5% water), available from Aldrich Chemical Company, Milwaukee, WI.</span></li>
    <li><span class="oli">The formation of styrene <strong>10</strong> was not 
      unexpected since fluoride ion can function as an effective base at elevated 
      temperature, Clark, J. H. Chem. Rev. 1980, 80, 429. Performing the reaction 
      at lower temperatures (20-40�C) resulted in increased reaction times (>24 
      h) and diminished <strong>9</strong>+<strong>10</strong> yields (<25 %).</span></li>
  </ol>
</div>
</body>
</html>